7K1P

Crystal structure of the second bromodomain (BD2) of human TAF1 bound to bromosporine

7K1P の概要

• エントリーDOI: 10.2210/pdb7k1p/pdb
• 分子名称: Transcription initiation factor TFIID subunit 1, Bromosporine, 1,2-ETHANEDIOL, ... (4 entities in total)
• 機能のキーワード: taf1, non-bet, bet, kinase inhibitor, atr, dual brd-kinase, gene regulation
• 由来する生物種: Homo sapiens (Human)
• タンパク質・核酸の鎖数: 1
• 化学式量合計: 16349.32

構造登録者

Karim, M.R.,Schonbrunn, E. (登録日: 2020-09-08, 公開日: 2021-09-22, 最終更新日: 2024-10-30)

主引用文献

Karim, R.M.,Yang, L.,Chen, L.,Bikowitz, M.J.,Lu, J.,Grassie, D.,Shultz, Z.P.,Lopchuk, J.M.,Chen, J.,Schonbrunn, E.
Discovery of Dual TAF1-ATR Inhibitors and Ligand-Induced Structural Changes of the TAF1 Tandem Bromodomain.
J.Med.Chem., 65:4182-4200, 2022

PubMed Abstract: Bromodomains regulate chromatin remodeling and gene transcription through recognition of acetylated lysines on histones and other proteins. Bromodomain-containing protein TAF1, a subunit of general transcription factor TFIID, initiates preinitiation complex formation and cellular transcription. TAF1 serves as a cofactor for certain oncogenic transcription factors and is implicated in regulating the p53 tumor suppressor. Therefore, TAF1 is a potential target to develop small molecule therapeutics for diseases arising from dysregulated transcription, such as cancer. Here, we report the ATR kinase inhibitor AZD6738 (Ceralasertib) and analogues thereof as bona fide inhibitors of TAF1. Crystallographic and small-angle X-ray scattering studies established that newly identified and previously reported inhibitors stabilize distinct structural states of the TAF1 tandem bromodomain through "open-closed" transitions and dimerization. Combined with functional studies on p53 signaling in cancer cell lines, the data provide new insights into the feasibility and challenges of TAF1 inhibitors as chemical probes and therapeutics.

PubMed: 35191694
DOI: 10.1021/acs.jmedchem.1c01999

実験手法

X-RAY DIFFRACTION (2.45 Å)